NCT02621385View on ClinicalTrials.gov

Study to Assess the Effect of Multiple Doses of Tradipitant on CYP3A4 Using Midazolam as a Substrate in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

February 29, 2016

Conditions
Healthy Volunteers
Interventions
DRUG

tradipitant

test agent

DRUG

Midazolam

substrate for drug-drug interaction assessment

Trial Locations (1)

6864

Vanda Investigational Site, Arzo

Sponsors

Collaborators (1)

Cross Research S.A.
All Listed Sponsors
collaborator

Cross Research S.A.

INDUSTRY

lead

Vanda Pharmaceuticals

INDUSTRY